Related Experiment Videos
Maximal airway narrowing in a general population.
A James1, D Lougheed, G Pearce-Pinto
1Departments of Pulmonary Physiology and Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia.
The American Review of Respiratory Disease
|October 1, 1992
Summary
This study characterizes airway hyperresponsiveness in a population sample using methacholine challenges. Respiratory symptoms and maximal changes in FEV1 are key indicators for identifying asthma and wheeze.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
- Clinical Research
Background:
- Airway hyperresponsiveness (AHR) is a hallmark of asthma.
- Characterizing AHR in population samples is crucial for understanding respiratory health.
- Methacholine challenge testing is a standard method for assessing AHR.
Purpose of the Study:
- To characterize airway responses to methacholine in a general population sample.
- To investigate the relationship between respiratory symptoms, smoking, and AHR parameters.
- To determine the diagnostic utility of AHR measures for asthma and wheeze.
Main Methods:
- 201 subjects underwent methacholine inhalation challenge.
- Respiratory symptoms, smoking habits, and changes in FEV1 (delta FEV1) were recorded.
- Dose-response curve parameters including maximal delta FEV1 and PD20 were derived.
Main Results:
- Maximal delta FEV1 was significantly correlated with PD20 (r = -0.64) and slope (r = 0.63).
- History of asthma or wheeze was associated with higher maximal delta FEV1 and lower PD20.
- Combined criteria of maximal delta FEV1 (50%) and PD20 (≤4 µmol) yielded higher likelihood ratios for asthma/wheeze.
Conclusions:
- Airway responsiveness patterns vary continuously and are related to clinical outcomes.
- Maximal FEV1 change and PD20 are significant predictors of asthma and wheeze.
- A plateau in the dose-response curve is less common in individuals with a history of asthma or wheeze.